Alpine Immune Sciences In...

NASDAQ: ALPN · Real-Time Price · USD
64.97
0.01 (0.02%)
At close: May 17, 2024, 10:00 PM

Alpine Immune Sciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
58.88M 30.06M 23.44M
Cost of Revenue
80.9M 597K 620K
Gross Profit
-22.03M 29.47M 22.82M
Operating Income
-44.25M -58.15M -49.86M
Interest Income
11.85M 3.29M 259K
Pretax Income
-32.08M -55.43M -50.42M
Net Income
-32.18M -57.76M -50.33M
Selling & General & Admin
22.22M 17.97M 14.56M
Research & Development
80.9M 70.24M 58.74M
Other Expenses
n/a -97K -4K
Operating Expenses
103.13M 88.21M 73.3M
Interest Expense
98K 476K 816K
Selling & Marketing Expenses
n/a n/a n/a
Cost & Expenses
103.13M 88.21M 73.3M
Income Tax Expense
103K 2.33M -87K
Shares Outstanding (Basic)
50M 33.44M 25.48M
Shares Outstanding (Diluted)
50M 33.44M 25.48M
EPS (Basic)
-0.64 -1.73 -1.98
EPS (Diluted)
-0.64 -1.73 -1.98
EBITDA
-43.67M -54.96M -49.6M
EBIT
-31.98M -54.96M -49.6M
Depreciation & Amortization
576K 3.19M 255K